ANACOR PHARMACEUTICALS INC COM
ANAC
ANAC was delisted on the 23rd of June, 2016.
107 hedge funds and large institutions have $596M invested in ANACOR PHARMACEUTICALS INC COM in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 31 reducing their positions, and 16 closing their positions.
87% more call options, than puts
Call options by funds: $2.08M | Put options by funds: $1.12M
52% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 31
19% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 16
2% more funds holding
Funds holding: 105 → 107 (+2)
9% less capital invested
Capital invested by funds: $653M → $596M (-$56.2M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.2M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$8.38M |
| 3 |
BC
Broadfin Capital
New York
|
+$7.12M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$2.83M |
| 5 |
Renaissance Technologies
New York
|
+$2.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$11.6M |
| 2 |
PC
PointState Capital
New York
|
-$5.78M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$5.49M |
| 4 |
ICRM
Insight Capital Research & Management
Walnut Creek,
California
|
-$3.76M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$2.65M |
ANAC Hedge Fund Activity: Q2 2014 in Review
107 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q2 2014, worth a combined $596M — down 8.6% from $653M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ANAC positions and 16 closed out — a net gain of 3 holders — while 47 added to existing stakes and 31 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $10.2M. The largest seller was Consonance Capital Management, cutting an estimated $11.6M.
- 107 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q2 2014, up from 105 in Q1 2014.
- Funds reported $596M of ANACOR PHARMACEUTICALS INC COM stock for Q2 2014, down 8.6% quarter-over-quarter.
- 19 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q2 2014 and 16 closed out, a net change of +3 holders.
- The largest ANACOR PHARMACEUTICALS INC COM buyer in Q2 2014 was Fidelity Investments, an estimated $10.2M added.
- The largest ANACOR PHARMACEUTICALS INC COM seller in Q2 2014 was Consonance Capital Management, an estimated $11.6M sold.
Based on aggregated 13F filings for Q2 2014.